SteerOn Research

Founded: 2017 • Age: 9 yrs
Chemistry and regulatory services for pharmaceutical and biotech industries.

About SteerOn Research

SteerOn Research is a company founded in 2017. SteerOn Research offers products and services including Discovery Chemistry and Toxicological Services.

  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Social LinkedIn Instagram
  • Legal Name Steeron Research Pvt. Ltd
  • Date of Incorporation 18 Aug, 2017
  • Jurisdiction Bangalore, Karnataka, India
Key Metrics
  • Annual Revenue
    ₹1.53 Cr

    FY 2025 · +318% YoY

  • Net Loss
    -₹18.9 Lakh

    FY 2025 · -12% margin

  • EBITDA
    -₹23.4 Lakh

    FY 2025 · -15% margin

Products & Services of SteerOn Research

SteerOn Research offers a comprehensive portfolio of products and services, including Discovery Chemistry and Toxicological Services.

Discovery Chemistry
Chemistry Services

Drug discovery processes are supported through integrated chemistry capabilities including computational, medicinal, synthetic, and analytical chemistry.

Toxicological Services
Regulatory Services

Toxicological assessments such as PDE, ADE, OEL calculations, genotoxic evaluations, and GRAS reports are conducted to aid in regulatory compliance.

Board of directors of Steeron Research Private Limited (SteerOn Research)

Steeron Research Private Limited is the primary company behind SteerOn Research. The board of Steeron Research Private Limited currently have 3 directors; the longest-serving is Shweta Singh, appointed in 2017.

DirectorDesignationAppointedTenureEntity
Shweta Singh
DIN 07901202
Director18 Aug 20179 yrs 1 moSteeron Research Private Limited
Puja Singh
DIN 07901187
Managing Director18 Aug 20179 yrs 1 moSteeron Research Private Limited
Saroj Kumar Singh
DIN 10354951
Additional Director21 Oct 20241 yr 11 moSteeron Research Private Limited

Financials of SteerOn Research

Figures of Steeron Research Private Limited, the primary company behind SteerOn Research, for FY 2025. Revenue was ₹1.53 Cr (+318% year on year). Net loss was -₹18.9 Lakh (-12% margin). EBITDA was -₹23.4 Lakh (-15% margin). Revenue has grown at a compounded annual rate of +54% over three years and +32% over five years.

  • ₹1.53 CrRevenue · FY 2025 · +318% YoY
  • -₹18.9 LakhNet loss · -12% margin
  • -₹23.4 LakhEBITDA · -15% margin
  • ₹1 LakhPaid-up capital
  • +54%Revenue CAGR, 3 years
  • +32%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Steeron Research Private Limited are on its company page.

Premium access

Detailed financial statements for SteerOn Research

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to SteerOn Research

10 companies that operate in the same segment as SteerOn Research (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Genetic services are provided by Colossal's laboratory operations.
2021Austin, Texas, United StatesUSD 617.6 M––
Research lab engaged in pharmacological measurements on therapeutic protein variants
2018United StatesUSD 78.19 M–22
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
2004Ahmedabad, Gujarat, India–USD 50.52 M902
Generic injectables for oncology and anesthesiology are manufactured.
1989Hyderabad, Telangana, India–USD 4.22 M228
Medical research labs are provided by GALY for scientific purposes.
2018Boston, Massachusetts, United StatesUSD 61.59 M–25
Laboratory focused on biotechnology & molecule research services
2018Cambridge, Massachusetts, United StatesUSD 32.68 M––
Laboratory delivers discovery & research in nuclear and particle physics
1947United States––2,436
Research and manufacturing of hemp products are conducted by BRC.
2017Monterey, California, United StatesUSD 25.26 M–16
Genome sequencing studies are conducted for medical research purposes.
2020Cambridge, Cambridgeshire, United KingdomUSD 11.26 M–12
Novel immunotherapy therapeutic targets are discovered through laboratory research.
2019Branford, Connecticut, United StatesUSD 92 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about SteerOn Research

SteerOn Research was founded in 2017.

The primary company behind SteerOn Research, Steeron Research Private Limited, reported revenue of β‚Ή1.53 Cr for FY 2025, up 318% year on year.

SteerOn Research is identified as a contract research organization that specializes in discovery chemistry services for pharmaceutical and biotech sectors. Toxicological assessments, including PDE, ADE, and OEL calculations, are provided to ensure safety and compliance in drug development. Pharmacovigilance and CMC consulting are offered to monitor adverse reactions and support progression from bench to market. Partnerships with various organizations, such as academic institutions, are maintained to deliver integrated solutions. Regulatory expertise is emphasized to facilitate innovative therapies while adhering to standards.

SteerOn Research offers Discovery Chemistry and Toxicological Services.

SteerOn Research operates through Steeron Research Private Limited.

The legal entities of SteerOn Research currently have 3 directors, including Saroj Kumar Singh, Shweta Singh, Puja Singh.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available